Usefulness of Combining Galectin-3 and BIVA Assessments in Predicting Short- and Long-Term Events in Patients Admitted for Acute Heart Failure

Baseline biomarkers as a function of the primary endpoint of events (in-hospital death and rehospitalization and death at 18-month follow-up) and death.

BioMed Research International

tab2

Table 2

Table 2: Usefulness of Combining Galectin-3 and BIVA Assessments in Predicting Short- and Long-Term Events in Patients Admitted for Acute Heart Failure 

Table 2 | Usefulness of Combining Galectin-3 and BIVA Assessments in Predicting Short- and Long-Term Events in Patients Admitted for Acute Heart Failure 